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The hippocampus is an elongated brain structure related to processing episodic memory 
and spatial navigation. The dorsal hippocampus plays an important role in spatial tasks (Lee & 
Kesner, 2003), while the ventral hippocampus is known to be involved with emotion (Fanselow 
& Dong, 2010). Previous work in our lab has shown that the dorsal and ventral sections within 
the same hemisphere work together during navigation (Lee et al., 2019).  The lab is currently 
determining how activity in the dorsal hippocampus impacts place cell firing in the ventral 
hippocampus. To accomplish this the dorsal hippocampus will be inactivated using Designer 
Receptors Exclusively Activated by Designer Drugs (DREADDs).   
To examine the impact of dorsal hippocampus inactivation, we analyzed the performance 
of rats in a spatial working memory version of the Morris Water Maze.  Latency and swim path 
to the platform were compared under conditions with and without DREADD activation. It was 
found that there were no differences in spatial navigation abilities when the rats received vehicle 
or drug injections. Histological analysis showed that the initial DREADDs surgery was 
unsuccessful, explaining this finding. 
 
Introduction 
Spatial navigation and the ability to remember the location of a reward are complex 
behaviors. An organism needs to orient itself and understand the spatial relations between 
objects. A common way to analyze an organism’s understanding of the space around them is 
through the use of experimental escape procedures. Within these tasks, animals are placed 
within an unfavorable environment and forced to use either local/non-spatial or extra-
maze/spatial cues to locate a safe space and remove themselves from the unfavorable condition 
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(Terry, 2009). The Morris Water Maze (MWM) is an example of an experimental escape 
procedure and is commonly used in rats to assess spatial learning and memory (Morris, 1981). 
Within the MWM task, the rats are placed within a large circular container of water and trained 
to seek refuge on a small platform. This task is spatial, as the unform surface of the water gives 
the rats no local cues to use to locate the platform.  
If the platform is left in the same location each day, the rat can access its memory of the 
task from days prior to more easily escape the water and locate the platform. This is referred to 
as a reference memory task. To make the task more difficult and be able to assess learning within 
each day (rather than from previous days), the location of the platform can be changed each day. 
If the platform’s location is varied on each testing day, the rat must learn that its memory of the 
location from previous days is not useful to complete the task on subsequent days. Rather, they 
must approach each day without as a novel task with a different ending location. This is referred 
to as a working memory task (Vorhees & Williams, 2006). 
The MWM task is one way to analyze performance in a spatial navigation task. To 
further understand this phenomenon, the brain region associated with these abilities must be 
considered. A brain region called the hippocampus has been shown to underly spatial 
navigation in both humans and rodents (Schmajuk, 1990; O’Keefe & Nadel, 1979). 
Interestingly this region is also responsible for memory formation in both species (Ekstrom et 
al., 2003). Within the hippocampus, individual cells, known as place cells, signal the location 
of the organism in its environment. These pyramidal cells within the hippocampus become 
active when an organism is in a particular location in the environment, commonly referred to as 
a place field. Many place fields together create a cognitive representation of the organism’s 
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environment that can be used to complete various navigational memory tasks (O'Keefe & 
Speakman, 1987).  
The hippocampus is a long structure with dorsal and ventral portions (Figure 1) that seem 
to have different functions. The dorsal hippocampus is known to play an important role in 
spatial, working memory tasks (Lee 
& Kesner, 2003). The ventral 
hippocampus is known to be 
involved with emotion (Fanselow & 
Dong, 2010). Previous work in our 
lab has shown that the dorsal and 
ventral sections within the same 
hemisphere work together during 
navigation (Lee et al., 2019). The lab 
is currently determining how activity 
in the dorsal hippocampus impacts 
place cell firing in the ventral hippocampus. We are using a Horseshoe Maze (Oler & Markus, 
2000) that has both an emotional (presumably ventral hippocampus) and spatial (presumably 
dorsal hippocampus) component. Rather than doing a permanent lesion or temporary 
inactivation using a drug such as muscimol, we would like to temporarily inactivate the dorsal 
hippocampus with Designer Receptors Exclusively Activated by Designer Drugs (DREADDs). 
DREADDs were selected as the inactivation technique because they require minimal 
invasiveness and maximal control of the brain area of interest (Smith et al. 2016). This will 
Figure 1: Hippocampus in rats, monkeys, and humans.  Note 
the elongated structure in all three with dorsal/posterior and 
ventral/ anterior regions (Strange et al. 2014) 
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allow for a comparison of the organisms’ behavior and cell activity multiple times with both a 
functional and inactivated dorsal hippocampus. 
My honor's project was to verify that the procedure for inactivating the dorsal 
hippocampus with DREADDS is successful. Since it is well known that an inactivated dorsal 
hippocampus impairs spatial memory, it was expected that rats with inactivated dorsal 
hippocampi will have more difficulty locating a hidden platform in a water maze. Expected 





A total of 5 virgin male Fischer’s (F344) rats (Envigo, IN) were used for these 
experiments. Two 12-month-old rats were used for the working and reference memory task and 
underwent DREADDs surgery and injection trials to analyze the effect of a potential dorsal 
hippocampal inactivation. Three additional, 11-month old rats began training on the working 
memory task. All rats were handled and tails were marked upon arrival. They were singly housed 
for the entirety of the experiment in an environment with a standard 12-hour light/12-hour dark 
cycle. They had unlimited access to food and water in their home cages. All rats had no previous 
training on other tasks. 
Throughout the experiment, the experimenters were blind to whether or not the rats 
received drug or vehicle injections to temporarily inactivate the dorsal hippocampus to prevent 
bias. All surgeries and injections were successful. The research protocol was approved by the 
University of Connecticut IACUC. 
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Apparatus 
 The water maze consisted of a water-filled plastic tub (dimensions: 140cm diameter, 
40cm height). A removable clear Plexiglas escape platform (15cm diameter) was submerged 
2cm beneath the water’s surface at varying locations each day. 
Behavioral Procedures  
General Procedure  
The rats were trained on the classic 
Morris Water Maze task. In this task, the 
platform was located 2cm under the surface 
of the water. Subjects were run four times 
each day, interleaved. Within these four 
trials, each rat was placed at 4 different 
starting locations in a pseudorandom order, 
always facing the wall, within the water maze. The rats were allowed a maximum swim time 
of 60 seconds to locate the hidden platform. If they were unable to locate the platform within 
this time, the experimenter guided them to the platform. Once the platform was reached, the 
rat was left for on it for 10 seconds. The rat was then removed, dried, and placed in a heated 
plastic tub. The location of the platform remained the same on all trials each day. Videos of 
all trials were recorded. Latency, or length of time required to reach the platform, was 
documented and analyzed during each day.  
Reference Memory Task 
For the reference memory task subjects, the platform location remained in the location 
as shown below for all testing days. 
Figure 2: Example of Morris Water Maze with 





Working Memory Task 
For the working memory task subjects, the platform locations were arranged in two 
different orientations. For the first part of the experiment, the rat had to locate a platform at 
one of eight locations each day, with the location changing from day to day. These locations 
are shown in Figure 4a. Due to a possible overtraining effect, the platform locations were 
changed to 9 different target locations, as shown in Figure 4b. 
   
 
 
Figure 3: MWM with the reference 
memory platform location marked. 
Figure 4: a) MWM with the 4 potential starting locations and original eight potential 
platform locations marked. b) MWM with the 4 potential starting locations and the 







As seen in Figure 5, the rats were first trained on the MWM task itself. Once they 
demonstrated proficiency (criteria was an average latency under 15 seconds for trials 2-4 for 4 
consecutive days), the rats were anesthetized and bilaterally injected with inhibitory 
DREADDS into the dorsal hippocampi. After a two-week recovery period, the animals were 
reintroduced to the classic MWM task. They were trained until their performance matched 
their pre-surgery level.  
A low dose of clozapine was injected to 
target the DREADDs and inactivate the dorsal 
hippocampus. These clozapine injections were 
alternated with a vehicle injection (experimenter 
blind to the drug condition) on every other day 
for a twelve-day period.  
Data Analysis Procedure 
Each day videos of all trials were 
recorded The videos for each trial were analyzed 
using an AI program called DeepLabCut in 
order to tease apart the rats’ specific behavioral patterns (Mathis et al., 2018). This program 
allowed us to measure the amount of time (latency) it took each rat to reach the platform, total 
distance travelled, and speed of the rats when in the Morris Water Maze. DeepLabCut was used 
Figure 5: Sequence of training used within this experiment.  
Figure 6: Screenshot of a rat during one trial 
in the Morris Water Maze. The three red rots 
on the rat’s nose and ears will be placed on all 
videos to be tracked as reference points within 
DeepLabCut. Video examples can be found 
here. 
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to track the average speeds, distances travelled, and latencies of the rat thought the ten-day 
injection period to garner information about whether or not the dorsal hippomcapus had been 
successfully inactivated (Figure 6). 
 
Results 
Reference Memory Task 
 Rat 23 was trained to locate a hidden platform in the MWM for many consecutive days. 
The location of the platform was changed from day to day at the beginning of the project (pre-
training days 1-19 and retraining days 1-27). The rat did not seem to be learning the task, so the 
decision was made to transition the task to the simpler reference memory task in which the 
location of the platform was the same throughout all trials on all days (Reference 1- onward). For 
clarity, only the reference memory task data are shown below. The amount of time, in sections, it 






 The overall training progress of the reference memory rat is shown above in Figure 7. As 
can be seen, the latencies of all trials seem to vary not only from day to day, but also from trial to 
trial within days. Within a reference memory task, one would expect the latency to reach the 
platform to be short if the subject has learned the task, as they can access their memory of the 
platform’s location from previous training days. To the right of the blue arrow, there does appear 
to be a decreased latency for most of the trials. Within the ten days of MWM reference task 
training, there was only one trial (Reference 4, trial 3) that exceeded twenty seconds. This 
variation is to be expected, as this data is only showing the performance of one rat. As shown by 























































































































































































































































































































































































































































































Latency Across Days for Rat 23
Figure 7: Latency to hidden platform, in seconds, for the reference memory task over the course of 
training. Each day consisted of 4 trials. Gray trials represent the latencies for pre-training before 
DREADDS surgery and re-training after DREADDS surgery. Orange trials represent 0.1mg/kg 
Clozapine injections. Blue trials represent DMSO/vehicle injections. All highlighted trials indicate the 
first trial on each training day. Black dashed line indicated when the subject was switched to the 
reference memory task.  
0.1mg/kg Clozapine 
DMSO 
Start of reference 
memory task 
Start of injection 
period 
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when injections were given. Analysis was conducted in order to further examine potential 
differences when the subject received Clozapine and DMSO/vehicle injections.  
 In order to determine if the injections themselves were causing a change in the physical 
abilities of the rat, speed (in centimeters per second) was analyzed.  
 
 
A repeated measures ANOVA was performed to determine how the day number and 
injection content (drug/vehicle) affected the speed of the rat on all injection days. Ignoring the 
effect of the trial number (i.e. first versus second versus third fourth), there was no difference in 
the speed of the rats based on the injection they received (i.e. Clozapine or DMSO) (F(1,4) = 
0.796 n.s.). As seen in Figure 8, the speed of the reference memory rat was relatively similar if 
the rat received DMSO or Clozapine injections. The speeds ranged from 15 to 20 centimeters per 
second, regardless of injection contents. This was the desired result, as we hoped that the 


















Vehicle (n = 5)
0.1 mg/kg (n = 5)
Figure 8: Mean speed travelled in cm/s(+/- SEM) during the vehicle and drug trials 
within the reference memory MWM task for all four trials. The blue bars represent 
the days in which the rat received vehicle/DMSO injections and the orange bars 
represent the days in which the rat received 0.1mg/kg of Clozapine. 
Repeated Measures 
Drug: F(1,4) = 0.796, n.s. 
Trial: F(3,12) = 0.942, n.s. 
Drug x Trial: F(3,12) = 2.883, p = 0.08 # 
No sig pairwise comparisons 
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Ignoring the effect of the injections’ contents, there was no difference in the speed of the 
rats based on the trial number (F(3,12) = 0.942, n.s.). As seen in Figure 8, the speed of the 
reference memory rat was relatively similar from trial to trial. During all trials, the rat swam 
between about 15 and 20 centimeters per second. This was the desired result, as we hoped that 
the injection had no effect on the physical ability of the rat to complete the task. 
No interaction was found between the trial number and injection contents. (F(3,12) = 
2.883, p = 0.08#). This suggests that whether or not a rat received Clozapine or DMSO on did 
not affect the speed of the rat when trying to locate the hidden platform within a given trial. 
Given the trending p-value (0.08), this interaction may have become significant if the rat 
received more injections and there was more data to be analyzed. 
 In order to determine if the injections caused a change in the spatial navigation of the rat, 





















Vehicle (n = 5)
0.1 mg/kg (n = 5)
Figure 9: Mean distance travelled in centimeters (+/- SEM) during the vehicle and 
drug trials within the reference memory MWM task for all four trials. The blue bars 
represent the days in which the rat received vehicle injections and the orange bars 
represent the days in which the rat received 0.1mg/kg of Clozapine. For reference, 
the maze is about 3m in diameter. 
Repeated Measures 
Drug: F(1,4) = 0.818, n.s. 
Trial: F(3,12) = 0.574, n.s. 
Drug x Trial: F(3,12) = 2.85, p = 0.082 # 
No sig pairwise comparisons 
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A repeated measures ANOVA was performed to determine how the day number and 
injection content (drug/vehicle) affected the distance the rat traveled during each trial on all 
injection days. Ignoring the effect of the trial number (i.e. first versus second versus third fourth), 
there was no difference in the distance travelled by the rat based on the injection they received 
(i.e. Clozapine or DMSO) (F(1,4) = 0.818 n.s.). As seen in Figure in Figure 9, the distance 
travelled by the reference memory rat was relatively similar when the rat received DMSO or 
Clozapine injections. When the rat received DMSO or Clozapine, it travelled about 200cm. 
Ignoring the effect of the injections’ contents, there was no difference in the distance 
travelled by the rat based on the trial number (F(3,12) = 0.574, n.s.). As seen in Figure 9, the 
distance travelled by the reference memory rat was relatively similar from trial to trial.  
No interaction was found between the trial number and injection contents. (F(3,12) = 
2.85, p = 0.082#). This suggests that whether or not the rat received Clozapine or DMSO on did 
not affect the distanced travelled to locate the hidden platform within a given trial. Given the 
trending p-value (0.082), this interaction may have become significant if the rat received more 
injections and there was more data to be analyzed. 
To further understand the great difference in distance travelled on the first trial for both 
vehicle and Clozapine injections, the relationship was further investigated. To complete the first 
trial each day, the rat must access its memory from previous training days to remember the 
location of the trial. On all subsequent trials, the rat can access this memory, but can also relearn 




A repeated measures ANOVA was performed to determine how the day number and 
injection content (drug/vehicle) affected the distance the rat traveled during the first trial and all 
subsequent trials on all injection days. Ignoring the effect of the trial number (i.e. first versus 
second versus third fourth), there was no difference in the distance travelled by the rat based on 
the injection they received (i.e. Clozapine or DMSO) (F(1,4) = 2.822, n.s.). As seen in Figure 10, 
the distance travelled by the reference memory rat was relatively similar when the rat received 
DMSO or Clozapine injections. When the rat received DMSO or Clozapine, it travelled about 
between 200 and 250cm. 
Ignoring the effect of the injections’ contents, there was no difference in the distance 






















Figure 10: Mean distance travelled in centimeters (+/- SEM) during the vehicle and 
drug trials for the first and average of second through fourth trials within the 
reference memory MWM task. The blue bars represent the days in which the rat 
received vehicle injections and the orange bars represent the days in which the rat 
received 0.1mg/kg of Clozapine. For reference, the maze is about 3m in diameter. 
Repeated Measures 
Drug: F(1,4) = 2.822, n.s. 
Trial: F(3,12) = 0.403, n.s. 
Drug x Trial: F(3,12) = 4.260, n.s. 
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No interaction was found between the trial number and injection contents. (F(1,4) = 
4.260, n.s.). This suggests that whether or not a rat received Clozapine or DMSO on did not 
affect the distanced travelled to locate the hidden platform on either the first or second through 
fourth trials. 
 Additionally, in order to determine if the injections caused a change in the spatial 
navigation of the rat, latency to the platform (in seconds) was analyzed.  
 
 
A repeated measures ANOVA was performed to determine how the day number and 
injection content (drug/vehicle) affected the time it took the rat to reach the platform during each 
trial on all injections days. Ignoring the effect of the trial number (i.e. first versus second versus 
third fourth), there was no difference in the latency to the platform based on the injection they 

















Vehicle (n = 5)
0.1 mg/kg (n = 5)
Figure 11: Mean latency elapsed in seconds (+/- SEM) during the vehicle and drug 
trials within the reference memory MWM task for all four trials. The blue bars 
represent the days in which the rat received vehicle injections and the orange bars 
represent the days in which the rat received 0.1mg/kg of Clozapine. 
Repeated Measures 
Drug: F(1,4) = 0.803, n.s. 
Trial: F(3,12) = 0.558, n.s. 
Drug x Trial: F(3,12) = 2.691, p = 0.093 # 
No sig pairwise comparisons 
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latencies were relatively similar when the rat received DMSO or Clozapine injections. When the 
rat received DMSO or Clozapine, it took about 10-12 seconds to locate the hidden platform. 
Ignoring the effect of the injections’ contents, there was no difference in the distance 
travelled by the rat based on the trial number (F(3,12) = 0.558, n.s.). As seen in Figure 11, the 
latencies were relatively similar from trial to trial.  
No interaction was found between the trial number and injection contents. (F(3,12) = 
2.691, p = 0.093#). This suggests that whether or not a rat received Clozapine or DMSO on did 
not affect the length of time it took the rat to locate the hidden platform within a given trial. 
Given the trending p-value (0.093), this interaction may have become significant if the rat 
received more injections and there was more data to be analyzed. 
To further understand the great difference in latency between the latency to the platform 
on the first trial for both vehicle and Clozapine injections, the relationship was further 
investigated. To complete the first trial each day, the rat must access its memory from previous 
training days to remember the location of the trial. On all subsequent trials, the rat can access this 
memory, but can also relearn the platform location, making these trials potentially different in 





A repeated measures ANOVA was performed to determine how the trial number and 
injection content (drug/vehicle) affected the time it took the rat to reach the platform during the 
first trial and all subsequent trials on all injections days. Ignoring the effect of the trial number 
(i.e. first versus second versus third fourth), there was no difference in the latency to the platform 
based on the injection they received (i.e. Clozapine or DMSO) (F(1,4) = 2.348, n.s.). As seen in 
Figure in Figure 12, the latencies were relatively similar when the rat received DMSO or 
Clozapine injections. When the rat received DMSO or Clozapine, it took about 10-12 seconds to 
locate the hidden platform. 
Ignoring the effect of the injections’ contents, there was no difference in the distance 
















Latency -- Trial 1 vs. Average Trials 2-4
Vehicle (n=5)
0.1 mg/kg (n=5)
Figure 12: Mean latency elapsed in seconds (+/- SEM) during the vehicle and drug 
trials for the first and average of second through fourth trials within the reference 
memory MWM task. The blue bars represent the days in which the rat received 
vehicle injections and the orange bars represent the days in which the rat received 
0.1mg/kg of Clozapine. 
2-4 
Repeated Measures 
Drug: F(1,4) = 2.348, n.s. 
Trial: F(3,12) = 0.378, n.s. 
Drug x Trial: F(3,12) = 3.727, n.s. 
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No interaction was found between the trial number and injection contents. (F(1,4) = 
3.727, n.s.). This suggests that whether or not a rat received Clozapine or DMSO on did not 
affect the length of time it took the rat to locate the hidden platform on either the first or second 
through fourth trials. 
Behavioral analysis highlighted that there was no effect of Clozapine on the speed, 
distance travelled, and latency to the platform for rat #23, contrary to expectations. If more data 
was collected, whether or not a rat received Clozapine or DMSO on may have affected the 
distance travelled and length of time it took the rat to locate the hidden platform within a given 
trial. 
After the training protocol was completed, the reference memory rat was perfused and the 
brain was sectioned and stained. The resulting images of the hippocampus were analyzed in 










As seen in Figure 13, the DREADDs virus reached certain parts of the dorsal 
hippocampus within the reference memory subject. Pink-colored areas were found to be very 
pronounced within the CA1 and CA3 regions of the right dorsal hippocampus, indicating that the 
DREADDs were successfully delivered to these areas. A fainter pink color on the left dorsal 
hippocampus indicates that some DREADDs virus reached this area, but less than what reached 
the right dorsal hippocampus.  
Histological analysis explained the lack of effect from Clozapine injections. Since the 
virus did not reach entire dorsal hippocampus, Clozapine injections could not completely 
inactivate this brain region. When Clozapine was injected, rat #23 could still use the active parts 
of its dorsal hippocampus to complete the MWM task. 
Figure 13: Histological analysis of fluorescent virus spread in the dorsal hippocampus of the 
reference memory subject. Blue regions are DAPI stain to target all cell bodies. Pink regions 
indicate the parts of the dorsal hippocampus that were successfully injected with the DREADDs 
virus. Top and bottom panels show two different images from the same subject (top: dorsal anterior, 
bottom: dorsal posterior) Note: injections were bilateral. 
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Working Memory Task 
 
 
The overall training progress of the working memory rat (#24) is shown above in Figure 
14. As can be seen, the latencies of all trials seem to vary not only from day to day, but also from 
trial to trial within days. Within a working memory task, one would expect the latency for the 
first trial of each day to be long, as the rat must “forget” the platform location from the previous 
training day and search for the platform’s new location. On subsequent trials on the same day, 
the rat is expected to take less time to locate the platform, as they can access their memory of the 
platform’s location from the first trial.  
As shown by the orange and blue latencies above, the latencies of the working memory 























































































































































































































































































































































































































































































Latency Across Days for Rat 24
Figure 14:  Latency to hidden platform, in seconds, for the working memory task over the course of 
training. Each day consisted of 4 trials. Gray trials represent the latencies for pre-training before 
DREADDS surgery and re-training after DREADDS surgery. All highlighted trials indicate the first 
trial on each training day. Orange trials represent 0.1mg/kg Clozapine injections. Blue trials represent 




Start of injection 
period 
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examine potential differences when the subject received Clozapine and DMSO/vehicle 
injections.  
 Each day videos of all trials were recorded. DeepLabCut was then used to track the 
average speeds, distances travelled, and latencies of the rat thought the ten day injection period. 
In order to determine if the injections themselves were causing a change in the physical abilities 
of the rat, speed (in centimeters per second) was analyzed.  
 
 
A repeated measures ANOVA was performed to determine how the day number and 
injection content (drug/vehicle) affected the speed of the rat on all injection days. Ignoring the 
effect of the trial number (i.e. first versus second versus third fourth), there was no difference in 
the speed of the rats based on the injection they received (i.e. Clozapine or DMSO) (F(1,4) = 


















Vehicle (n = 5)
0.1 mg/kg (n = 5)
Figure 15: Mean speed travelled in cm/s(+/- SEM) during the vehicle and drug trials 
within the working memory MWM task for all four trials. The blue bars represent 
the days in which the rat received vehicle/DMSO injections and the orange bars 
represent the days in which the rat received 0.1mg/kg of Clozapine. 
Repeated Measures 
Drug: F(1,3) = 1.167, n.s. 
Trial: F(3,9) = 2.151, n.s. 
Drug x Trial: F(3,9) = 1.233, n.s. 
No sig pairwise comparisons 
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similar if the rat received DMSO or Clozapine injections. The speeds were about 20 centimeters 
per second, regardless of injection contents. This was the desired result, as we hoped that the 
injection had no effect on the physical ability of the rat to complete the task. 
Ignoring the effect of the injections’ contents, there was no difference in the speed of the 
rats based on the trial number (F(3,9) = 2.151, n.s.). As seen in Figure 15, the speed of the 
reference memory rat was relatively similar from trial to trial. During all trials, the rat swam 
between about 20 centimeters per second. This was the desired result, as we hoped that the 
injection had no effect on the physical ability of the rat to complete the task. 
No interaction was found between the trial number and injection contents. (F(3,9) = 
1.233, n.s.) This suggests that whether or not a rat received Clozapine or DMSO on did not affect 
the speed of the rat when trying to locate the hidden platform within a given trial.  
 In order to determine if the injections caused a change in the spatial navigation of the 






A repeated measures ANOVA was performed to determine how the trial number and 
injection content (drug/vehicle) affected the distance the rat traveled during each trial on all 
injection days. Ignoring the effect of the trial number (i.e. first versus second versus third fourth), 
there was no difference in the distance travelled by the rat based on the injection they received 
(i.e. Clozapine or DMSO) (F(1,4) = 1.325, n.s.). As seen in Figure 16, the distance travelled by 
the working memory rat was relatively similar when the rat received DMSO or Clozapine 
injections. When the rat received DMSO or Clozapine, it travelled about 500cm during the first 
trial and about 150cm during trials 2-4.  
Ignoring the effect of the injections’ contents, there was a difference in the distance 






















Vehicle (n = 5)
0.1 mg/kg (n = 5)
Figure 16: Mean distance travelled in centimeters (+/- SEM) during the vehicle and 
drug trials within the working memory MWM task for all four trials. The blue bars 
represent the days in which the rat received vehicle injections and the orange bars 
represent the days in which the rat received 0.1mg/kg of Clozapine. For reference, 
the maze is about 3m in diameter. 
Repeated Measures 
Drug: F(1,3) = 1.325, n.s. 
Trial: F(3,9) = 4.342, p < 0.05* 
Drug x Trial: F(3,9) = 1.643, n.s. 
No sig pairwise comparisons 
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distance travelled by the working memory rat was different from trial to trial. The working 
memory subject travelled about 500cm during the first trial and about 150cm during trials 2-4. 
No interaction was found between the trial number and injection contents. (F(3,12) = 
1.643, n.s.). This suggests that whether or not a rat received Clozapine or DMSO on did not 
affect the distanced travelled to locate the hidden platform within a given trial.  
 Additionally, in order to determine if the injections caused a change in the spatial 
navigation of the rat, latency to the platform (in seconds) was analyzed.  
 
 
A repeated measures ANOVA was performed to determine how the day number and 
injection content (drug/vehicle) affected the time it took the rat to reach the platform during each 
trial on all injections days. Ignoring the effect of the trial number (i.e. first versus second versus 

















Vehicle (n = 5)
0.1 mg/kg (n = 5)
Figure 17: Mean latency elapsed in seconds (+/- SEM) during the vehicle and drug 
trials within the working memory MWM task for all four trials. The blue bars 
represent the days in which the rat received vehicle injections and the orange bars 
represent the days in which the rat received 0.1mg/kg of Clozapine. 
Repeated Measures 
Drug: F(1,3) = 1.134, n.s. 
Trial: F(3,9) = 2.252, n.s. 
Drug x Trial: F(3,9) = 1.27, n.s. 
No sig pairwise comparisons 
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received (i.e. Clozapine or DMSO) (F(1,4) = 1.134, n.s.). As seen in Figure in Figure 17, the 
latencies were relatively similar when the rat received DMSO or Clozapine injections. When the 
rat received DMSO or Clozapine, it took about 30 seconds to locate the platform during the first 
trial and about 7 seconds during trials 2-4.  
Ignoring the effect of the injections’ contents, there was no difference in the distance 
travelled by the rat based on the trial number (F(3,9) = 2.252, n.s.). As seen in Figure 17, the 
latencies were relatively similar from trial to trial. The working memory subject took about 30 
seconds to locate the platform during the first trial and about 7 seconds during trials 2-4. 
No interaction was found between the trial number and injection contents. (F(3,9) = 1.27, 
n.s.). This suggests that whether or not a rat received Clozapine or DMSO on did not affect the 
length of time it took the rat to locate the hidden platform within a given trial.  
Behavioral analysis highlighted that there was no effect of Clozapine on the speed, 
distance travelled, and latency to the platform for rat #24, contrary to expectations.  
After the training protocol was completed, the working memory rat was perfused and the 
brain was sectioned and stained. The resulting images of the hippocampus were analyzed in 













      
 
As seen in Figure 18, the DREADDs virus did not reach the entire dorsal hippocampus. 
Pink-colored areas were found within the left CA3 and part of the left CA1 regions. Little to no 
virus seems to have reached the right dorsal hippocampus. 
Histological analysis explained the lack of effect from Clozapine injections. Since the 
virus did not reach entire dorsal hippocampus, Clozapine injections could not completely 
inactivate this brain region. When Clozapine was injected, rat #23 could still use the active parts 
of its dorsal hippocampus to complete the MWM task. 
Figure 18: Histological analysis of fluorescent virus spread in the dorsal 
hippocampus of the working memory subject. Blue regions are DAPI stain to 
target all cell bodies. Pink regions indicate the parts of the dorsal hippocampus 
that were successfully injected with the DREADDs virus. Top and bottom panels 
show two different images from the same subject (top: dorsal anterior, bottom: 
dorsal posterior). Note: injections were bilateral.  
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In order to further understand the effectiveness of the DREADDs inactivation 
mechanism, three more subjects have been trained on the working memory task. The location of 




The first seven days of training for the first working memory rat, rat #27, are shown 
above in Figure 19. As can be seen, the latencies of all trials seem to vary not only from day to 
day, bit also from trial to trial within days. Within a working memory task, one would expect the 
latency for the first trial of each day to be long, as the rat must “forget” the platform location 
from the previous training day and search for the platform’s new location. On subsequent trials 
on the same day, the rat is expected to take less time to locate the platform, as they can access 



































































































Latency Across Days for New Working Memory Rat #27
Figure 19:  Latency to hidden platform, in seconds, for the working memory task over the course of 
the first seven days of training. Each day consisted of 4 trials. All highlighted trials indicate the first 
trial on each training day. 
 
Repeated Measures 
Trial: F(1,4) = 6.657, p< 0.005* 
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As seen in Figure 19, there appears to be a variability in the amount of time it took rat 
#27 to reach the platform during trials 2-4. For example, it took 60 seconds to locate the platform 
on the second trial of Day 1 and 2 of training, but less than 5 seconds on the second trial of Day 
3. This could be a result of the increased and decreased distances between the alternating starting 
locations and the hidden platform’s location. If the rat is placed at the starting location very close 
to the platform, it may require less time to complete the trial. If the rat is placed far from the 
platform location, it may require more time. 
To determine the significance of this variability and to assess the proficiency of the rat, a 
repeated measures ANOVA was performed to determine how the trial number affected the time 
it took the rat to reach the platform during the first trials and all subsequent trials on all training 
days (trial 1 vs. average trials 2-4). There was a decrease in the amount of time taken to find the 
hidden platform on trials 2-4 relative to trial 1 (F(1,4) = 6.657, p< 0.005). As seen in Figure 19, 
the latencies for trials 2-4 appear to be less than the latencies for trial 1. 





The first seven days of training for rat #28 are shown above in Figure 20. The same 
results were expected for this rat as were for the rat discussed previously. As seen in Figure 20, 
there appears to be a variability in the amount of time it took rat #28 to reach the platform during 
trials 2-4. For example, it took 60 seconds to locate the platform on the fourth trial of Day 1 and 
about 5 seconds during the fourth trial on Day 3. This could be a result of the increased and 
decreased distances between the alternating starting locations and the hidden platform’s location. 
If the rat is placed at the starting location very close to the platform, it may require less time to 



































































































Latency Across Days for New Working Memory Rat #28
Figure 20:  Latency to hidden platform, in seconds, for the working memory task over the course of 
the first seven days of training. Each day consisted of 4 trials. All highlighted trials indicate the first 
trial on each training day. 
 
Repeated Measures 
Trial: F(1,4) = 21.255, p< 0.005* 
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To determine the significance of this variability and to assess the proficiency of the rat, a 
repeated measures ANOVA was performed to determine how the trial number affected the time 
it took the rat to reach the platform during the first trials and all subsequent trials on all training 
days (trial 1 vs. average trials 2-4). There was a decrease in the amount of time taken to find the 
hidden platform on trials 2-4 relative to trial 1 (F(1,4) = 621.255, p< 0.005). As seen in Figure 
20, the latencies for trials 2-4 appear to be less than the latencies for trial 1. 
The same protocol and analysis was completed for a third rat.  
 
       
 
 
The first seven days of training for rat #29 are shown above in Figure 21. The same 



































































































Latency Across Days for New Working Memory Rat #29
Figure 21:  Latency to hidden platform, in seconds, for the working memory task over the 
course of the first seven days of training. Each day consisted of 4 trials. All highlighted trials 
indicate the first trial on each training day. 
 
Repeated Measures 
Trial: F(1,4) = 0.166, n.s. 
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there appears to be a variability in the amount of time it took rat #29 to reach the platform during 
trials 2-4. For example, it took about 45 seconds to locate the platform on the fourth trial of Day 
1 and about 10 seconds during the fourth trials on Day 3 and 4. This could be a result of the 
increased and decreased distances between the alternating starting locations and the hidden 
platform’s location. If the rat is placed at the starting location very close to the platform, it may 
require less time to complete the trial. If the rat is placed far from the platform location, it may 
require more time. 
To determine the significance of this variability and to assess the proficiency of the rat, a 
repeated measures ANOVA was performed to determine how the trial number affected the time 
it took the rat to reach the platform during the first trials and all subsequent trials on all training 
days (trial 1 vs. average trials 2-4). There was no change in the amount of time taken to find the 
hidden platform on trials 2-4 relative to trial 1 (F(1,4) = 0.166, n.s.). As seen in Figure 21, there 
does not appear to be any relative trend in the latencies for trial 1 and trials 2-4. Rather than 
seeing a progressive decrease as trials progress, the length of time the rat required to reach the 
platform varies, suggesting that more training is required in order to move forward with 
DREADDs surgery, the next step in the training protocol.  
 
Discussion 
 The reference and working memory water maze tasks provide different ways to assess 
whether or not the entire bilateral dorsal hippocampus has been inactivated in the subjects. Since 
both are known to assess spatial navigation in rats (Jarrard, 1993) the assets and drawbacks of 
both tasks can be assessed. The reference memory task is a simpler, less complex task. This task 
requires activation of existing spatial memory acquired throughout training. Since the platform 
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remains in the same location each day, the task requires less training. The subject must 
remember the location of the platform from previous training days, and simply find that location. 
Thus, the reference memory subjects can reach proficiency in a shorter period of time.  
 On the other hand, the working memory task is innately more complex. Since the 
platform is moved to different locations on each training day, the subject must “forget” the 
location of the platform from the previous training day and, instead, search for the platform’s 
adjusted location during the first trial and “remember” this new location during the second 
through fourth trials. As opposed to being able to activate existing spatial memories in a 
reference memory task, subjects must perform a spatial learning task when completing a 
working memory task. Because of this increased complexity, the working memory task requires 
a longer training period and some rats are unable to learn this task.  
Overall, the working memory task should be a better way to assess whether or not the 
dorsal hippocampus has been inactivated. Its complexity requires the subject to treat each 
training day as a new learning experience, thus requiring an active the dorsal hippocampus to 
locate the adjusted platform location, rather than simply a memory of the location from previous 
training days. 
Reference Memory Task 
It was expected that Clozapine injections would activate the DREADDs within the dorsal 
hippocampus of the reference memory task rat, causing impaired social navigation. If the 
DREADDs were successfully activated by Clozapine, there would have been a difference in the 
spatial navigation abilities of the rat to complete the reference memory task. 
Behavioral analysis during injection trials showed that there was no change in the speed 
following either vehicle or Clozapine injection (Figure 8). During all trials, the rat swam at a 
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speed of about 15 to 20 centimeters per second, regardless of the injections contents (Figure 8). 
This was expected, and allowed us to conclude that either the drug and/or the injection did not 
cause any change in the physical abilities of the rat, thus allowing us to move forward and 
analyze the distances and latencies during all injection days.  
It was expected that there would be an increase in distance travelled by the reference 
memory rat when Clozapine was injected, as the drug was expected to target the DREADDs and 
inactivate the dorsal hippocampus. However, there was no effect of the Clozapine on the distance 
travelled by the reference memory rat (Figures 9&10). The distance travelled by the reference 
memory rat was about 200cm when the rat received DMSO or Clozapine injections (Figure 9) 
suggesting that the dorsal hippocampus had not been successfully inactivated.  
A large variation in the distance travelled during the first trial was found both between 
the DMSO and Clozapine injection days and within all Clozapine injection days (Figure 9). This 
could have been a result of increased and decreased distances between the alternating starting 
locations and the hidden platform’s location. If the rat is placed at the starting location very close 
to the platform, it may need to swim a decreased distance to locate the platform. If the rat is 
placed far from the platform location, it may need to swim a greater distance. 
Similarly, it was expected that there would be an increase in the amount of time to locate 
the hidden platform for the reference memory rat when Clozapine was injected, as the drug was 
expected to target the DREADDs and inactivate the dorsal hippocampus. However, there was no 
effect of the Clozapine on the latency for the reference memory subject (Figures 11&12). When 
the rat received DMSO or Clozapine, it took about 10-12 seconds to locate the hidden platform 
(Figure 11), suggesting that the dorsal hippocampus had not been successfully inactivated.  
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A large variation in the latencies during the first trial was found both between the DMSO 
and Clozapine injection days and within all Clozapine injection days (Figure 11). This could 
have been a result of increased and decreased distances between the alternating starting locations 
and the hidden platform’s location. If the rat is placed at the starting location very close to the 
platform, it may require less time to complete the trial. If the rat is placed far from the platform 
location, it may require more time. 
Findings were also analyzed using the histology garnered after perfusion. The DREADDs 
virus seemed to reach a significant portion of the bilateral dorsal hippocampus within this subject 
(Figure 13). However, the amount of virus that reached each region seemed to vary, thus 
potentially leaving some spatial navigation abilities intact, confirming the lack of effect found 
from Clozapine injections on distance travelled and latency to the hidden platform (Figures 
9&11).  
Working Memory Task 
Expectations for the working memory task were similar to the reference memory task, as 
they are both commonly used to assess spatial navigation in rats. If the DREADDs were 
successfully activated by Clozapine, there would have been a difference in the spatial navigation 
abilities of the rat to complete the working memory task. It was expected that Clozapine 
injections would activate the DREADDs within the dorsal hippocampus of the working memory 
task rat, causing impaired social navigation.  
Behavioral analysis during injection trials showed that there was no change in the speed 
following either vehicle or Clozapine injection (Figure 15). During all trials, the rat swam at a 
speed of about 20 centimeters per second, regardless of the injections contents (Figure 15). This 
was expected, and allowed us to conclude that either the drug and/or the injection did not cause 
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any change in the physical abilities of the rat, thus allowing us to move forward and analyze the 
distances and latencies during all injection days.  
It was expected that there would be an increase in distance travelled by the working 
memory rat when Clozapine was injected, as the drug was expected to target the DREADDs and 
inactivate the dorsal hippocampus. However, there was no effect of the Clozapine on the distance 
travelled by the reference memory rat (Figure 16). The distance travelled by the reference 
memory rat was about relatively similar when the rat received DMSO or Clozapine injections -- 
500cm during the first trial and about 150cm during trials 2-4 (Figure 16). This greatest distance 
on the first trial and decreasing distances on the second through fourth trials are expected given 
the working memory task in which the platform’s location changes each day. 
Similarly, it was expected that there would be an increase in the amount of time to locate 
the hidden platform for the working memory rat when Clozapine was injected, as the drug was 
expected to target the DREADDs and inactivate the dorsal hippocampus. However, there was no 
effect of the Clozapine on the latency for the reference memory subject (Figure 17). When the rat 
received DMSO or Clozapine, it took about 30 seconds to locate the platform during the first 
trial and about 7 seconds during trials 2-4  (Figure 17), suggesting that the dorsal hippocampus 
had not been successfully inactivated. This greatest latency on the first trial and decreasing 
latencies on the second through fourth trials are expected given the working memory task in 
which the platform’s location changes each day. 
Findings were also analyzed using the histology garnered after perfusion. The DREADDs 
virus seemed to reach the left CA3 and part of the left CA1 regions of the dorsal hippocampus 
(Figure 18). Given that the virus did not seem to reach the entire bilateral dorsal hippocampus, 
some spatial navigation abilities could have been left intact, confirming the lack of effect found 
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from Clozapine injections on distance travelled and latency to the hidden platform (Figures 
16&17). 
For the three additional working memory rats, it was expected that the length of time 
required to locate the hidden platform would be greatest during the first trial each day and 
decrease for trials 2-4 as the rats could use their memory of the platform’s location from the first 
trial to help locate it on subsequent trials. The first two working memory rats exhibited this 
expected behavior (Figure 19&20, p< 0.005). This suggest that the rats are learning the task 
correctly and are becoming proficient. If trends continue, DREADDs surgery can be completed 
and the rat can move forward through the training protocol. However, the third working memory 
rat did not exhibit such a trend, as there was no difference in the latencies for trial 1 and the 
average of trials 2-4 (Figure 21). This suggests that this rat has not properly learned the task, and 
thus requires more training before DREADDs surgery can be completed.  
Future Directions 
 Given the lack of successful inactivation with these two subjects, this project will 
continue with more subjects. More rats will be trained on the MWM task until they are 
proficient, and an adjusted DREADDs surgery protocol will be used to bilaterally inject 
inhibitory DREADDs into their dorsal hippocampi.  
Once complete inactivation of the dorsal hippocampus is achieved, the same drug 
delivery mechanism used within this task will then be used in the Horseshoe Maze (Oler & 
Markus, 2000). Since the Horseshoe maze is more complex than the water maze and the effects 
of dorsal hippocampus impairments on the water maze are well known, the results of the 
inactivation will allow us to confirm the effectiveness of the drug delivery mechanism to be used 
within the more complex task.  
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